ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0LIF Ultragenyx Pharmaceutical Inc

64.79
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 133k2.61M51.5M103.71M271.03M351.41M363.33M434.25M
Operating Income -248.01M-328.94M-371.37M-424.17M-330.12M-381.74M-648.92M-569.21M
Pre Tax Income -245.84M-318.34M-197.1M-399.44M-185.36M-452.98M-701.73M-608.46M
Net Income -245.87M-302.14M-197.61M-402.73M-186.57M-454.03M-707.42M-606.64M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -5.962-6.841-3.885-6.963-2.792-6.547-10.078-7.388
EBIT -249.63M-322.41M-206.64M-424.96M-329.51M-383.42M-650.49M-569.55M
EBITDA -244.58M-323.12M-351.84M-415.63M-317.86M-368.51M-630.7M-543.2M